Insiders · Profile

Vivaldi Coelho Rogerio

Director at Crinetics Pharmaceuticals · President and CEO at Minerva Neurosciences. Filing since 1 Jul 2014. CIK 0001610381

Company
Date
Role
Action
Shares
Amount
Of holding
2 Jul 2026
Director
Sold on a plan
3,000
$120.00K
13.5%
12 Mar 2026
Director
Sold on a plan
5,000
$180.76K
23.5%
8 Jun 2023
Director
Bought
5,000
$110.30K
opened
1 Jul 2014
President and CEO
Bought
41,667
$250.00K
opened
4 decisions on file.